Cancer and renal insufficiency results of the BIRMA study

BACKGROUND: Half of anticancer drugs are predominantly excreted in urine. Dosage adjustment in renal insufficiency (RI) is, therefore, a crucial issue. Moreover, patients with abnormal renal function are at high risk for drug-induced nephrotoxicity. The Belgian Renal Insufficiency and Anticancer Med...

Descripción completa

Detalles Bibliográficos
Autores principales: Janus, N, Launay-vacher, V, Byloos, E, Machiels, J-P, Duck, L, Kerger, J, Wynendaele, W, Canon, J-L, Lybaert, W, Nortier, J, Deray, G, Wildiers, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008606/
https://www.ncbi.nlm.nih.gov/pubmed/21063408
http://dx.doi.org/10.1038/sj.bjc.6605979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008606/
https://www.ncbi.nlm.nih.gov/pubmed/21063408
http://dx.doi.org/10.1038/sj.bjc.6605979

Ejemplares similares